About Almut Winterstein
Almut Winterstein received her pharmacy degree from Friedrich Wilhelm University in Bonn, Germany and her PhD in Pharmacoepidemiology from the Charité Humboldt University in Berlin, Germany. She holds the position of Professor and Chair in the Department of Pharmaceutical Outcomes and Policy at the College of Pharmacy and is the founding Director of the Center for Drug Evaluation and Safety, both at the University of Florida. She has an affiliate appointment in the Department of Epidemiology at the Colleges of Medicine and Public Health and Health Professions. In 2017, she was named the Dr. Robert and Barbara Crisafi Chair for Medication Safety in recognition of her research on drug safety and on devising ways to improve medication use.
Since joining the University of Florida in 2000, Winterstein has served as principal investigator on more than 25 extramurally funded grants and contracts and published more than 400 manuscripts and conference abstracts. Her research interests have centered on the post-marketing evaluation of drugs in pediatrics and perinatal care, infectious disease and psychiatry and the evaluation and improvement of quality surrounding medication use using real-world data. As expert in drug safety, she has chaired the Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee from 2012-2018. Recognizing her contributions in pharmacoepidemiology, Dr. Winterstein was inducted as a fellow of the International Society of Pharmacoepidemiology in 2013 and currently serves as president of the society. Before she became department chair in 2016, Dr. Winterstein served as graduate program director in her department. She has chaired more than 21 PhD committees and was awarded the UF-wide Dissertation Advisor/Mentoring award for her excellence in graduate training.
- Patient Safety
- Program evaluation
The research provides important information to support the FDA’s REMS program which aims to prevent fetal exposure to mycophenolate.
The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.
The study published in JAMA Network Open found a substantial number of patients are being prescribed a loop diuretic for leg swelling induced by calcium channel blocker.
At the meeting, she was presented an “Outstanding Service Award,” for her exceptional leadership in the field of drug safety.